Dermatosis neutrofílicas

Wallach, 2006, From acute febrile neutrophilic dermatosis to neutrophilic disease: Forty years of clinical research, J Am Acad Dermatol, 55, 1066, 10.1016/j.jaad.2006.07.016 Soutou, 2011, Les dermatoses neutrophiliques, Rev Med Interne, 32, 306, 10.1016/j.revmed.2010.08.023 Saurat, 2009, Concept de dermatoses neutrophiliques Mahé, 2002, Pyoderma gangrenosum, Presse Med, 31, 1476 Brahimi, 2009, Pyoderma gangrenosum avec abcès splénique aseptique, Ann Dermatol Venereol, 136, 46, 10.1016/j.annder.2008.10.019 Marie, 1998, Focal aseptic osteitis underlying neutrophilic dermatosis, Br J Dermatol, 139, 744, 10.1046/j.1365-2133.1998.02482.x Kanazawa, 2007, Autoinflammatory syndromes with a dermatological perspective, J Dermatol, 34, 601, 10.1111/j.1346-8138.2007.00342.x Nesterovitch, 2011, Alteration in the gene encoding protein tyrosine phosphatase nonreceptor type 6 (PTPN6/SHP1) may contribute to neutrophilic dermatoses, Am J Pathol, 178, 1434, 10.1016/j.ajpath.2010.12.035 Dabade, 2011, Diagnosis and treatment of the neutrophilic dermatoses (pyoderma gangrenosum, Sweet's syndrome), Dermatol Ther, 24, 273, 10.1111/j.1529-8019.2011.01403.x Brooklyn, 2006, Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial, Gut, 55, 505, 10.1136/gut.2005.074815 Lipsker, 2010, Anakinra for difficult-to-treat neutrophilic panniculitis: IL-1 blockade as a promising treatment option for neutrophil-mediated inflammatory skin disease, Dermatology, 220, 264, 10.1159/000280436 Viguier, 2010, Successful treatment of generalized pustular psoriasis with the interleukin-1-receptor antagonist Anakinra: lack of correlation with IL1RN mutations, Ann Intern Med, 153, 66, 10.7326/0003-4819-153-1-201007060-00030